FDA Approves Unknown Drug — HIKMA
HIKMA is positioned to bolster its market share following the FDA's approval of ANDA087003, a move expected to expand revenue streams as the generic enters the competitive landscape.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day